In a move reflecting the growing convergence between decentralised finance and digital healthcare, PrestoDoctor now accepts cryptocurrency payments for its online medical cannabis consultations. The initiative was announced today by its parent company, Dogecoin Cash, Inc., listed on the OTCQB under the ticker DOGP.
This expansion introduces support for 14 leading digital currencies, including Bitcoin, Ethereum and Dogecoin, the latter being the firm’s eponymous token and a key element of its corporate identity.
A strategic step in digital health and decentralised finance
This development comes amid a broader strategic push by Dogecoin Cash, Inc. to harness blockchain technology across the healthcare and financial sectors. Through PrestoDoctor, the company offers HIPAA-compliant telemedicine services in several U.S. states, enabling patients to obtain legal medical cannabis evaluations without physical appointments.
“Digital assets are no longer fringe,” commented David Tobias, Chief Executive Officer of Dogecoin Cash. “Their integration into healthcare payments provides flexibility and convenience for a new generation of patients.”
The accepted cryptocurrencies include:
- Bitcoin (BTC)
- Ethereum (ETH)
- USD Coin (USDC)
- Tether (USDT)
- Binance Coin (BNB)
- Dogecoin (DOGE)
- Litecoin (LTC)
- Tron (TRX)
- Monero (XMR)
- Polygon (MATIC)
- Bitcoin Cash (BCH)
- Shiba Inu (SHIB)
- Solana (SOL)
- DAI
Between innovation and patient privacy
For PrestoDoctor, the integration of crypto payments is not solely a question of technological adaptation. According to Kyle Powers, the company’s CEO, it also responds to growing demand for discretion and autonomy in patient care.
“Incorporating crypto is as much about enhancing patient privacy as it is about embracing innovation,” Powers stated. “Our users are increasingly comfortable with digital assets — and we want our platform to reflect that reality.”
Traditional payment methods, such as debit and credit cards, remain available, ensuring no disruption for existing patients.
Regulatory challenges and opportunities
While the move reflects confidence in the long-term role of cryptocurrencies, it also raises regulatory questions. The use of crypto in healthcare payments exists in a legal grey area, particularly in the context of cannabis, which remains tightly regulated at both state and federal levels in the U.S.
Nevertheless, Dogecoin Cash views this integration as an opportunity to position itself at the vanguard of healthcare innovation. “By offering decentralised payment options, we’re staying ahead of market trends and preparing for a more blockchain-integrated future,” said Tobias.
About Dogecoin Cash, Inc.
Dogecoin Cash, Inc. (OTCQB: DOGP) is a publicly traded enterprise focused on the advancement of blockchain technologies in high-impact sectors such as healthcare, consumer services and financial innovation. Its subsidiary, PrestoDoctor, delivers secure, telehealth-based medical cannabis evaluations across multiple jurisdictions.
